Perspectives for Using Exosomes for Targeted Delivery in HER2-Positive Breast Cancer

The document discussed the potential of using exosomes for targeted drug delivery in treating aggressive HER2-positive breast cancer. It highlighted the promise of exosomes associated with DARPin G3 scaffold proteins as a novel method for addressing this type of cancer, which was one of the most common malignant tumors. The research emphasized the urgency of finding new treatment approaches for HER2-positive breast cancer.